Evolution of resistance to drugs in HIV-1-infected patients failing antiretroviral therapy

AIDS
Rami KantorW Jeffrey Fessel

Abstract

The optimal time for changing failing antiretroviral therapy (ART) is not known. It involves balancing the risk of exhausting future treatment options against the risk of developing increased drug resistance. The frequency with which new drug-resistance mutations (DRM) developed and their potential consequences in patients continuing unchanged treatment despite persistent viremia were assessed. A retrospective study of consecutive sequence samples from 106 patients at one institution with viral load (VL) of more than 400 copies/ml, with no change in ART for more than 2 months despite virologic failure. Two consecutive pol sequences, CD4 cell counts and VL were analyzed to quantify the development of new DRM and to identify changes in immunologic and virologic parameters. Genotypic susceptibility scores (GSS) and viral drug susceptibilities were calculated by a computer program (HIVDB). Poisson log-linear regression models were used to predict the expected number of mutations at the second time point. : After a median of 14 months of continued ART, 75% (80 of 106) of patients acquired new DRM and were assigned a significantly lower GSS, potentially limiting the success of future ART. The development of new DRM was proportional t...Continue Reading

References

Nov 1, 1995·AIDS Research and Human Retroviruses·M O SalminenF E McCutchan
Jul 5, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·N Hawley-FossA D Badley
Jul 11, 2001·AIDS Patient Care and STDs·D W Fitzgerald, T B Simon
Jul 4, 2002·JAMA : the Journal of the American Medical Association·Patrick G YeniPaul A Volberding
Jan 7, 2003·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Chris BirchSean Emery
Jan 10, 2003·Nucleic Acids Research·Soo-Yon RheeRobert W Shafer
Jun 28, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Martin S HirschDouglas D Richman

❮ Previous
Next ❯

Citations

Oct 20, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Hiroyu HatanoSteven G Deeks
Sep 21, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Tejal GandhiPowel Kazanjian
May 11, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Nitin K HingankarRamesh S Paranjape
Jun 17, 2005·AIDS·Mauro ZaccarelliUNKNOWN Collaborative Group for Clinical Use of HIV Genotype Resistance Test (GRT) at National Institute for Infectious Diseases Laz
Nov 1, 2006·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Matthew Bidwell GoetzWilliam A O'Brien
Jan 6, 2010·Current Opinion in HIV and AIDS·Jeannette L Aldous, Richard H Haubrich
Dec 18, 2012·Journal of Clinical Microbiology·Moussa ThiamCoumba Toure-Kane
Jul 28, 2010·Journal of Virology·Michael E AbramStephen H Hughes
Jun 24, 2008·Bulletin of the World Health Organization·Eugène MessouXavier Anglaret
Apr 28, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Benjamin P WestleyRami Kantor
Aug 27, 2005·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Sonia NapravnikJoseph J Eron
Sep 5, 2006·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Jody LawrenceJohn D Baxter
Jun 25, 2009·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Lutgarde LynenRobert Colebunders
Oct 1, 2011·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Jérémie MuwongaMartine Peeters
Oct 4, 2011·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Michael J McConnellPilar Perez-Romero
Jan 1, 2007·Current Opinion in HIV and AIDS·Steven G Deeks, Jeffrey N Martin
Nov 1, 2006·Current Opinion in HIV and AIDS·Andrew N PhillipsJens D Lundgren
Nov 1, 2006·Current Opinion in HIV and AIDS·Christine Katlama, Jade Ghosn
Feb 25, 2009·La Revue de médecine interne·F Chaix, C Goujard
Nov 13, 2007·Drug Discovery Today·Dominique J PepperRobert J Wilkinson
Mar 10, 2007·International Journal of Antimicrobial Agents·Ravindra Kumar Gupta, Deenan Pillay

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.